Survival analysis of famotidine administration routes in non-traumatic intracerebral hemorrhage patients: based on the MIMIC-IV database

Non-IV famotidine administration significantly improves 30-day survival of ICH patients, especially for those with normal ICP, compared to IV administration.

Authors

Publication Details

Journal
Expert Review of Pharmacoeconomics & Outcomes Research
Published
2024-08-19
DOI
https://doi.org/10.1080/14737167.2024.2394113
Primary Topic
Intracerebral and Subarachnoid Hemorrhage Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Survival analysis of famotidine administration routes in non-traumatic intracerebral hemorrhage patients: based on the MIMIC-IV database

Ling Chen, Yan Wang
Expert Review of Pharmacoeconomics & Outcomes Research
Intracerebral and Subarachnoid Hemorrhage Research
article

Survival analysis of famotidine administration routes in non-traumatic intracerebral hemorrhage patients: based on the MIMIC-IV database

Ling Chen, Yan Wang
article en

Abstract

Non-IV famotidine administration significantly improves 30-day survival of ICH patients, especially for those with normal ICP, compared to IV administration.

Expert Review of Pharmacoeconomics & Outcomes ResearchVol. 25(1)
Openalex Percentile: Top 79%
Intracerebral and Subarachnoid Hemorrhage Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Survival analysis of famotidine administration routes in non-traumatic intracerebral hemorrhage patients: based on the MIMIC-IV database — Ling Chen, Yan Wang · Expert Review of Pharmacoeconomics & Outcomes Research (2024) | TGRS Research Map | TGRS